Corsini, E., Liesivuori, J., Vergieva, T., Van Loveren, H
mitoK ATP , Mitochondrial ATP-Sensitive Potassium Channel
Experts say patients taking GLP-1-based medications should monitor for mood changes and report symptoms such as: New or worsening depression Anxiety or emotional changes Suicidal thoughts More research is needed to determine whether these drugs directly affect mood or whether changes are related to factors such as rapid weight loss, hormonal changes or other metabolic effects
At TRT MD, we are committed to helping our patients achieve optimal health through safe and effective peptide therapies
We already have effective FDA-approved options available today in Florida, including GLP-1 and dual-agonist medications
Copper peptides, including GHK-Cu, are effective in reducing wrinkles and improving skin elasticity